Literature DB >> 26003214

The cemented twin-peg Oxford partial knee replacement survivorship: a cohort study.

Stephen H White1, Sharon Roberts2, Jan Herman Kuiper3.   

Abstract

BACKGROUND: A new twin-peg version of the Oxford knee was introduced in 2003. However, until now there has been no information about its survivorship. The aim of this study was to determine the survivorship, and the patients' perception of outcome over time.
METHODS: A cohort of all patients treated from 2003 until 2009 using the twin-peg Oxford partial knee was contacted. The main indication for treatment was anteromedial osteoarthritis (AMOA). The Oxford Knee Score (OKS), American Knee Society Functional (AKS-F) score and satisfaction rate were obtained, and the time-to-failure was used to perform a survival analysis.
RESULTS: There were 249 patients treated, with 288 medial cemented implants. Of these, 248 patients with 287 implants could be contacted and implant survival or failure was verified. Their mean age was 67years (range: 34-94). The mean follow-up time was 5.1years (maximum: 9.2). The nine years cumulative implant survival rate for all cases using revision for any reason to define failure was 98% (95% CI, 84 to 100). There were no cases of femoral loosening. The mean OKS was 22 pre-operatively, 41 at two years, and 41 at final review, at which point 96% of patients were very or fairly pleased with the result.
CONCLUSION: The survivorship of the twin-peg knee was better than that of the single peg knee at our centre, and appeared no worse than the results of the single peg knee at the originating centre. It can offer secure femoral fixation, sustained clinical benefit and patient satisfaction. LEVEL OF EVIDENCE: Level IV case-series.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anteromedial osteoarthritis; Oxford twin-peg cemented knee replacement; Patient reported outcome measures (PROMs); Survival analysis; Unicompartmental knee replacement

Mesh:

Substances:

Year:  2015        PMID: 26003214     DOI: 10.1016/j.knee.2015.03.011

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  6 in total

1.  Isolated medial patellofemoral ligament reconstruction significantly improved quality of life in patients with recurrent patella dislocation.

Authors:  Theodoros Bouras; Edmond U; Ashley Brown; Peter Gallacher; Andrew Barnett
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-28       Impact factor: 4.342

2.  Satisfaction and Functional Outcomes in Unicompartmental Compared with Total Knee Arthroplasty: Radiographically Matched Cohort Analysis.

Authors:  Kirsten Jansen; Mitchell Beckert; Evan R Deckard; Mary Ziemba-Davis; R Michael Meneghini
Journal:  JB JS Open Access       Date:  2020-09-28

3.  Early Results of Oxford Mobile Bearing Medial Unicompartmental Knee Replacement (UKR) with the Microplasty Instrumentation: An Indian Experience.

Authors:  Sahil Gaba; Naman Wahal; Deepak Gautam; Hemant Pandit; Vijay Kumar; Rajesh Malhotra
Journal:  Arch Bone Jt Surg       Date:  2018-07

4.  A matched comparison of revision rates of cemented Oxford Unicompartmental Knee Replacements with Single and Twin Peg femoral components, based on data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.

Authors:  Hasan R Mohammad; Gulraj S Matharu; Andrew Judge; David W Murray
Journal:  Acta Orthop       Date:  2020-04-16       Impact factor: 3.717

5.  Early outcomes of twin-peg mobile-bearing unicompartmental knee arthroplasty compared with primary total knee arthroplasty.

Authors:  Z C Lum; A V Lombardi; J M Hurst; M J Morris; J B Adams; K R Berend
Journal:  Bone Joint J       Date:  2016-10       Impact factor: 5.082

6.  Two pegs are better than one: rare mode of femoral component failure in unicompartmental arthroplasty requiring revision to total knee arthroplasty.

Authors:  Ryan Stancil; Nathan Summers; Douglas Van Citters; Adam Sassoon
Journal:  Arthroplast Today       Date:  2017-11-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.